Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats

Endocrine

Volumn 37, Issue 3, 2010, Pages 489-496

  Shivaswamy, Vijay ^a,b   McClure, Marissa ^a   Passer, Joel ^a   Frahm, Christin ^a   Ochsner, Luann ^a   Erickson, Judi ^a   Bennett, Robert G ^a,b   Hamel, Frederick G ^a,b   Larsen, Jennifer L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Apoptosis; Diabetes; Immunosuppression; Rats

Indexed keywords

GLUCOSE; INSULIN; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GROWTH RATE; HOMEOSTASIS; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MONOTHERAPY; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; REVERSAL REACTION; SPRAGUE DAWLEY RAT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77952090325     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9332-6     Document Type: Article

References (30)

1. J Hjelmesaeth A Hartmann T Leivestad H Holdaas S Sagedal M Olstad, et al. 2006 The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Kidney Int. 69 3 588 595 10.1038/sj.ki.5000116 1:STN:280:DC%2BD287mtlOrtA%3D%3D 16395250 (Pubitemid 43164454)
2. J. Davidson, A. Wilkinson, J. Dantal, F. Dotta, H. Haller, D. Hernandez et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. in Proceedings of an International Expert Panel Meeting, Barcelona, Spain, 19 February 2003. Transplantation 75(10 Suppl), SS3-24 (2003)
3. E Sulanc JT Lane SE Puumala GC Groggel LE Wrenshall RB Stevens 2005 New-onset diabetes after kidney transplantation: an application of 2003 international guidelines Transplantation 80 7 945 952 10.1097/01.TP.0000176482. 63122.03 16249743 (Pubitemid 41552891)
4. JL Larsen RG Bennett T Burkman AL Ramirez S Yamamoto J Gulizia, et al. 2006 Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats Transplantation 82 4 466 470 10.1097/01.tp.0000229384.22217.15 1:CAS:528:DC%2BD28XotlOitb8%3D 16926589 (Pubitemid 44290251)
5. L Ghisdal NB Bouchta N Broeders L Crenier AD Hoang D Abramowicz, et al. 2008 Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature Transpl. Int. 21 2 146 151 1:CAS:528: DC%2BD1cXivF2itr8%3D 17971033
6. M Ramos-Cebrian JV Torregrosa A Gutierrez-Dalmau F Oppenheimer JM Campistol 2007 Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation Transplant. Proc. 39 7 2251 2253 10.1016/j.transproceed.2007.06.035 1:CAS:528: DC%2BD2sXhtVOgtLzJ 17889154 (Pubitemid 47418145)
7. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 344(8920), 423-428 (1994)
8. JD Pirsch J Miller MH Deierhoi F Vincenti RS Filo 1997 A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group Transplantation 63 7 977 983 10.1097/00007890-199704150-00013 1:CAS:528:DyaK2sXjtFerurw%3D 9112351 (Pubitemid 27173021)
9. FG Cosio TE Pesavento K Osei ML Henry RM Ferguson 2001 Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years Kidney Int. 59 2 732 737 10.1046/j.1523-1755.2001. 059002732.x 1:STN:280:DC%2BD3M7ptl2qtQ%3D%3D 11168956 (Pubitemid 32157939)
10. F Vincenti S Friman E Scheuermann L Rostaing T Jenssen JM Campistol, et al. 2007 Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am. J. Transplant. 7 6 1506 1514 10.1111/j.1600-6143.2007.01749.x 1:CAS:528: DC%2BD2sXntVSnsL4%3D 17359512 (Pubitemid 46776239)
11. RS Woodward MA Schnitzler J Baty JA Lowell L Lopez-Rocafort S Haider, et al. 2003 Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am. J. Transplant. 3 5 590 598 10.1034/j.1600-6143.2003.00082.x 12752315 (Pubitemid 36612842)
12. E Porrini JM Moreno A Osuna R Benitez I Lampreabe JM Diaz, et al. 2008 Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study Transplantation 85 8 1133 1138 10.1097/TP.0b013e31816b16bd 1:CAS:528:DC%2BD1cXltVGktrs%3D 18431233 (Pubitemid 351590191)
13. YS Chien YT Chen CH Chuang YT Cheng FR Chuang H Hsieh 2008 Incidence and risk factors of new-onset diabetes mellitus after renal transplantation Transplant. Proc. 40 7 2409 2411 10.1016/j.transproceed.2008.06.034 18790250
14. M Veroux D Corona G Giuffrida M Gagliano M Sorbello C Virgilio, et al. 2008 New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression Transplant. Proc. 40 6 1885 1887 10.1016/j.transproceed.2008. 06.005 1:STN:280:DC%2BD1cvpsVKiug%3D%3D 18675079
15. O Johnston CL Rose AC Webster JS Gill 2008 Sirolimus is associated with new-onset diabetes in kidney transplant recipients J. Am. Soc. Nephrol. 19 7 1411 1418 10.1681/ASN.2007111202 18385422
16. CT Bussiere JR Lakey AM Shapiro GS Korbutt 2006 The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells Diabetologia 49 10 2341 2349 10.1007/s00125-006-0374-5 1:CAS:528:DC%2BD28XptF2kur4%3D 16896936 (Pubitemid 44359095)
17. E Bell X Cao JA Moibi SR Greene R Young M Trucco, et al. 2003 Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets Diabetes 52 11 2731 2739 10.2337/diabetes.52.11.2731 1:CAS:528:DC%2BD3sXovVagt7s%3D 14578291 (Pubitemid 37339702)
18. E Zahr RD Molano A Pileggi H Ichii SS Jose N Bocca, et al. 2007 Rapamycin impairs in vivo proliferation of islet beta-cells Transplantation 84 12 1576 1583 10.1097/01.tp.0000296035.48728.28 1:CAS:528:DC%2BD1cXmvVWq 18165767
19. W Sui H Zou G Zou Q Yan H Chen W Che, et al. 2008 Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation Transpl. Immunol. 20 1-2 95 98 10.1016/j.trim.2008.07.003 1:CAS:528:DC%2BD1cXhtlyksr7I 18703143
20. HA Hakeam AH Al-Jedai SM Raza K Hamawi 2008 Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients Ann. Transplant. 13 2 46 53 1:CAS:528: DC%2BD1MXisVClt78%3D 18566560
21. M Fraenkel M Ketzinel-Gilad Y Ariav O Pappo M Karaca J Castel, et al. 2008 mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes Diabetes 57 4 945 957 10.2337/db07-0922 1:CAS:528:DC%2BD1cXksVGkuro%3D 18174523
22. JJ Gibbons RT Abraham K Yu 2009 Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth Semin. Oncol. 36 Suppl 3 S3 S17 10.1053/j.seminoncol.2009.10.011 1:CAS:528:DC%2BC3cXpvFCitQ%3D%3D 19963098
23. CB Drachenberg DK Klassen MR Weir A Wiland JC Fink ST Bartlett, et al. 1999 Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation Transplantation 68 3 396 402 10.1097/00007890-199908150-00012 1:CAS:528:DyaK1MXlslKjtb8%3D 10459544 (Pubitemid 29384108)
24. MF Crutchlow RD Bloom 2007 Transplant-associated hyperglycemia: a new look at an old problem Clin. J. Am. Soc. Nephrol. 2 2 343 355 10.2215/CJN.03671106 1:CAS:528:DC%2BD2sXjs1yktrY%3D 17699434
25. E Oetjen D Baun S Beimesche D Krause I Cierny R Blume, et al. 2003 Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice Mol. Pharmacol. 63 6 1289 1295 10.1124/mol.63.6.1289 1:CAS:528:DC%2BD3sXkt1Sgsr4%3D 12761338 (Pubitemid 36627223)
26. RG Radu S Fujimoto E Mukai M Takehiro D Shimono K Nabe, et al. 2005 Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity Am. J. Physiol. Endocrinol. Metab. 288 2 E365 E371 10.1152/ajpendo.00390.2004 1:CAS:528:DC%2BD2MXhsVCkt7o%3D 15479952 (Pubitemid 40110645)
27. JB Redmon LK Olson MB Armstrong MJ Greene RP Robertson 1996 Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells J. Clin. Invest. 98 12 2786 2793 10.1172/JCI119105 1:CAS:528:DyaK2sXislSg 8981925
28. Y Uchizono M Iwase U Nakamura N Sasaki D Goto M Iida 2004 Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling Endocrinology 145 5 2264 2272 10.1210/en.2003-1152 1:CAS:528:DC%2BD2cXjsV2jsr0%3D 14962991 (Pubitemid 38535055)
29. A Volosov KL Napoli SJ Soldin 2001 Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry Clin. Biochem. 34 4 285 290 10.1016/S0009-9120(01)00235-1 1:CAS:528:DC%2BD3MXlvF2qs7k%3D 11440728 (Pubitemid 32607570)
30. R Muniyappa H Chen R Muzumdar FH Einstein X Yan LQ Yue, et al. 2009 Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats Am. J. Physiol. Endocrinol. Metab. 297 E1023 E1029 10.1152/ajpendo.00397.2009 1:CAS:528:DC%2BD1MXhsVahsbfM